The disparity between funding for eye research vs. the high cost of sight-loss in the UK

Saved in:
Bibliographic Details
Published in:Eye (London) 2023-03, Vol.37 (4), p.584-586
Main Authors: Dewing, Jennifer M., Lotery, Andrew J., Ratnayaka, J. Arjuna
Format: Article
Language:English
Subjects:
692/308
706/648
Age
Blindness
Cancer
Cataracts
Charities
Comment
Costs
Diabetic retinopathy
Disease
Humans
Laboratory Medicine
Macular degeneration
Medical research
Medicine
Medicine & Public Health
Ophthalmology
Pharmaceutical Sciences/Technology
Research funding
Surgery
Surgical Oncology
United Kingdom
Vascular endothelial growth factor
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c474t-e4b82fae794cf7a64920b4e2b8b59653df3d2d1e659ccd40c26590f078e854483
cites cdi_FETCH-LOGICAL-c474t-e4b82fae794cf7a64920b4e2b8b59653df3d2d1e659ccd40c26590f078e854483
container_end_page 586
container_issue 4
container_start_page 584
container_title Eye (London)
container_volume 37
creator Dewing, Jennifer M.
Lotery, Andrew J.
Ratnayaka, J. Arjuna
description
doi_str_mv 10.1038/s41433-022-02228-7
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9998460</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2785038077</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-e4b82fae794cf7a64920b4e2b8b59653df3d2d1e659ccd40c26590f078e854483</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS0EokPLH2CBLLFhk-I4TmxvkFDFS63UTSt1ZznO9cRVxh7spGj-PXc6pVAWLPzS-e6xrw8hb2p2WrNGfSiiFk1TMc73g6tKPiOrWsiuakUrnpMV0y2rULk5Iq9KuWUMRclekqOmqzuplViRm6sR6BDK1uYw72gP80-ASP0ShxDX1KdMYQc0QwGb3UjvyimdsWQM65G6VGaaPC14mKsplUJDvJevz0_IC2-nAq8f1mNy_eXz1dm36uLy6_ezTxeVE1LMFYhecW9BauG8tJ3QnPUCeK_6VndtM_hm4EMNXaudGwRzHHfMM6lAtUKo5ph8PPhul34Dg4M4ZzuZbQ4bm3cm2WCeKjGMZp3ujNb4AR1Dg_cPBjn9WKDMZhOKg2myEdJSDJe10h3OHNF3_6C3ackR20NKtZgJkxIpfqBcxh_J4B8fUzOzD84cgjMYmrkPzuyL3v7dxmPJ76QQaA5AQSmuIf-5-z-2vwDj3qON</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2785038077</pqid></control><display><type>article</type><title>The disparity between funding for eye research vs. the high cost of sight-loss in the UK</title><source>Springer Link</source><source>PubMed Central</source><creator>Dewing, Jennifer M. ; Lotery, Andrew J. ; Ratnayaka, J. Arjuna</creator><creatorcontrib>Dewing, Jennifer M. ; Lotery, Andrew J. ; Ratnayaka, J. Arjuna</creatorcontrib><identifier>ISSN: 0950-222X</identifier><identifier>EISSN: 1476-5454</identifier><identifier>DOI: 10.1038/s41433-022-02228-7</identifier><identifier>PMID: 36167984</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/308 ; 706/648 ; Age ; Blindness ; Cancer ; Cataracts ; Charities ; Comment ; Costs ; Diabetic retinopathy ; Disease ; Humans ; Laboratory Medicine ; Macular degeneration ; Medical research ; Medicine ; Medicine &amp; Public Health ; Ophthalmology ; Pharmaceutical Sciences/Technology ; Research funding ; Surgery ; Surgical Oncology ; United Kingdom ; Vascular endothelial growth factor</subject><ispartof>Eye (London), 2023-03, Vol.37 (4), p.584-586</ispartof><rights>The Author(s) 2022</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-e4b82fae794cf7a64920b4e2b8b59653df3d2d1e659ccd40c26590f078e854483</citedby><cites>FETCH-LOGICAL-c474t-e4b82fae794cf7a64920b4e2b8b59653df3d2d1e659ccd40c26590f078e854483</cites><orcidid>0000-0002-1027-6938 ; 0000-0001-5541-4305</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998460/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998460/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36167984$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dewing, Jennifer M.</creatorcontrib><creatorcontrib>Lotery, Andrew J.</creatorcontrib><creatorcontrib>Ratnayaka, J. Arjuna</creatorcontrib><title>The disparity between funding for eye research vs. the high cost of sight-loss in the UK</title><title>Eye (London)</title><addtitle>Eye</addtitle><addtitle>Eye (Lond)</addtitle><subject>692/308</subject><subject>706/648</subject><subject>Age</subject><subject>Blindness</subject><subject>Cancer</subject><subject>Cataracts</subject><subject>Charities</subject><subject>Comment</subject><subject>Costs</subject><subject>Diabetic retinopathy</subject><subject>Disease</subject><subject>Humans</subject><subject>Laboratory Medicine</subject><subject>Macular degeneration</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Ophthalmology</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Research funding</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>United Kingdom</subject><subject>Vascular endothelial growth factor</subject><issn>0950-222X</issn><issn>1476-5454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kUtv1DAUhS0EokPLH2CBLLFhk-I4TmxvkFDFS63UTSt1ZznO9cRVxh7spGj-PXc6pVAWLPzS-e6xrw8hb2p2WrNGfSiiFk1TMc73g6tKPiOrWsiuakUrnpMV0y2rULk5Iq9KuWUMRclekqOmqzuplViRm6sR6BDK1uYw72gP80-ASP0ShxDX1KdMYQc0QwGb3UjvyimdsWQM65G6VGaaPC14mKsplUJDvJevz0_IC2-nAq8f1mNy_eXz1dm36uLy6_ezTxeVE1LMFYhecW9BauG8tJ3QnPUCeK_6VndtM_hm4EMNXaudGwRzHHfMM6lAtUKo5ph8PPhul34Dg4M4ZzuZbQ4bm3cm2WCeKjGMZp3ujNb4AR1Dg_cPBjn9WKDMZhOKg2myEdJSDJe10h3OHNF3_6C3ackR20NKtZgJkxIpfqBcxh_J4B8fUzOzD84cgjMYmrkPzuyL3v7dxmPJ76QQaA5AQSmuIf-5-z-2vwDj3qON</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Dewing, Jennifer M.</creator><creator>Lotery, Andrew J.</creator><creator>Ratnayaka, J. Arjuna</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1027-6938</orcidid><orcidid>https://orcid.org/0000-0001-5541-4305</orcidid></search><sort><creationdate>20230301</creationdate><title>The disparity between funding for eye research vs. the high cost of sight-loss in the UK</title><author>Dewing, Jennifer M. ; Lotery, Andrew J. ; Ratnayaka, J. Arjuna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-e4b82fae794cf7a64920b4e2b8b59653df3d2d1e659ccd40c26590f078e854483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>692/308</topic><topic>706/648</topic><topic>Age</topic><topic>Blindness</topic><topic>Cancer</topic><topic>Cataracts</topic><topic>Charities</topic><topic>Comment</topic><topic>Costs</topic><topic>Diabetic retinopathy</topic><topic>Disease</topic><topic>Humans</topic><topic>Laboratory Medicine</topic><topic>Macular degeneration</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Ophthalmology</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Research funding</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>United Kingdom</topic><topic>Vascular endothelial growth factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dewing, Jennifer M.</creatorcontrib><creatorcontrib>Lotery, Andrew J.</creatorcontrib><creatorcontrib>Ratnayaka, J. Arjuna</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Databases</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Eye (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dewing, Jennifer M.</au><au>Lotery, Andrew J.</au><au>Ratnayaka, J. Arjuna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The disparity between funding for eye research vs. the high cost of sight-loss in the UK</atitle><jtitle>Eye (London)</jtitle><stitle>Eye</stitle><addtitle>Eye (Lond)</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>37</volume><issue>4</issue><spage>584</spage><epage>586</epage><pages>584-586</pages><issn>0950-222X</issn><eissn>1476-5454</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>36167984</pmid><doi>10.1038/s41433-022-02228-7</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-1027-6938</orcidid><orcidid>https://orcid.org/0000-0001-5541-4305</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-222X
ispartof Eye (London), 2023-03, Vol.37 (4), p.584-586
issn 0950-222X
1476-5454
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9998460
source Springer Link; PubMed Central
subjects 692/308
706/648
Age
Blindness
Cancer
Cataracts
Charities
Comment
Costs
Diabetic retinopathy
Disease
Humans
Laboratory Medicine
Macular degeneration
Medical research
Medicine
Medicine & Public Health
Ophthalmology
Pharmaceutical Sciences/Technology
Research funding
Surgery
Surgical Oncology
United Kingdom
Vascular endothelial growth factor
title The disparity between funding for eye research vs. the high cost of sight-loss in the UK
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A35%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20disparity%20between%20funding%20for%20eye%20research%20vs.%20the%20high%20cost%20of%20sight-loss%20in%20the%20UK&rft.jtitle=Eye%20(London)&rft.au=Dewing,%20Jennifer%20M.&rft.date=2023-03-01&rft.volume=37&rft.issue=4&rft.spage=584&rft.epage=586&rft.pages=584-586&rft.issn=0950-222X&rft.eissn=1476-5454&rft_id=info:doi/10.1038/s41433-022-02228-7&rft_dat=%3Cproquest_pubme%3E2785038077%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-e4b82fae794cf7a64920b4e2b8b59653df3d2d1e659ccd40c26590f078e854483%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2785038077&rft_id=info:pmid/36167984&rfr_iscdi=true